Small Molecule Drugs Targeting Viral Polymerases
Pharmaceuticals · 20.05.2024 · 17 (5) · 661
DOI: 10.3390/ph17050661 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 20.05.2024. Verfasst von Deborah Palazzotti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 204 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Recovery and Resilience Plan (NRRP) by the Italian Ministry of University and Research (MUR), EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, INF-ACT Cascade Open Call 2023.
Abstract (Originalsprache)
Small molecules that specifically target viral polymerases—crucial enzymes governing viral genome transcription and replication—play a pivotal role in combating viral infections. Presently, approved polymerase inhibitors cover nine human viruses, spanning both DNA and RNA viruses. This review provides a comprehensive analysis of these licensed drugs, encompassing nucleoside/nucleotide inhibitors (NIs), non-nucleoside inhibitors (NNIs), and mutagenic agents. For each compound, we describe the specific targeted virus and related polymerase enzyme, the mechanism of action, and the relevant bioactivity data. This wealth of information serves as a valuable resource for researchers actively engaged in antiviral drug discovery efforts, offering a complete overview of established strategies as well as insights for shaping the development of next-generation antiviral therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy.
ORCID-Profile: Giuseppe Manfroni, Violetta Cecchetti, Andrea Astolfi, Maria Letizia Barreca
Förderung
- National Recovery and Resilience Plan (NRRP) by the Italian Ministry of University and Research (MUR)
- EU funding within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
- INF-ACT Cascade Open Call 2023
Zitieren
APA
Palazzotti, D., Sguilla, M., Manfroni, G., Cecchetti, V., Astolfi, A., & Barreca, M. L. (2024). Small Molecule Drugs Targeting Viral Polymerases. Pharmaceuticals, 17(5), 661. https://doi.org/10.3390/ph17050661
Vancouver
Palazzotti D, Sguilla M, Manfroni G, Cecchetti V, Astolfi A, Barreca ML. Small Molecule Drugs Targeting Viral Polymerases. Pharmaceuticals. 2024;17(5):661. doi:10.3390/ph17050661
BibTeX
@article{Palazzotti2024,
author = {Palazzotti, Deborah and Sguilla, Martina and Manfroni, Giuseppe and Cecchetti, Violetta and Astolfi, Andrea and Barreca, Maria Letizia},
title = {Small Molecule Drugs Targeting Viral Polymerases},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {5},
pages = {661},
doi = {10.3390/ph17050661}
}
EUVIMED